PanTera to supply Ac-225 to Bayer

PanTera, a Belgian joint venture created by Ion Beam Applications (IBA) and SCK CEN, has signed a capacity reservation agreement with pharmaceutical giant Bayer for the supply of actinium-225 starting in the second half of 2024. An alpha-emitting radioisotope with a half-life of 10 days, Ac-225 has shown potential for treating various types of cancer through targeted alpha therapy.